CULLINAN ONCOLOGY INC's ticker is CGEM and the CUSIP is 230031106. A total of 107 filers reported holding CULLINAN ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 2.12 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,306,095 | -9.4% | 254,817 | +7.7% | 0.00% | – |
| Q2 2023 | $2,545,149 | +0.1% | 236,538 | -4.8% | 0.00% | -100.0% |
| Q1 2023 | $2,542,953 | -16.6% | 248,578 | -14.0% | 0.00% | 0.0% |
| Q4 2022 | $3,050,374 | -13.1% | 289,135 | +5.5% | 0.00% | 0.0% |
| Q3 2022 | $3,512,000 | +1.7% | 273,983 | +1.7% | 0.00% | 0.0% |
| Q2 2022 | $3,453,000 | +38.0% | 269,277 | +12.7% | 0.00% | – |
| Q1 2022 | $2,502,000 | -29.9% | 238,943 | +3.3% | 0.00% | -100.0% |
| Q4 2021 | $3,571,000 | -30.9% | 231,383 | +1.0% | 0.00% | 0.0% |
| Q3 2021 | $5,168,000 | +51.6% | 229,003 | +73.0% | 0.00% | 0.0% |
| Q2 2021 | $3,409,000 | -42.1% | 132,374 | -6.3% | 0.00% | 0.0% |
| Q1 2021 | $5,885,000 | – | 141,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM BioImpact LLC | 7,648,268 | $78,241,782 | 20.33% |
| CHI Advisors LLC | 3,349,460 | $34,264,977 | 9.10% |
| Nextech Invest Ltd. | 1,221,145 | $12,492,313 | 5.21% |
| BVF INC/IL | 3,196,701 | $32,702,251 | 1.20% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 265,032 | $2,711,277 | 1.12% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $5,115,000 | 0.76% |
| Atom Investors LP | 120,109 | $1,228,715 | 0.67% |
| Boxer Capital, LLC | 1,074,082 | $10,988 | 0.54% |
| SVB FINANCIAL GROUP | 20,274 | $207,403 | 0.40% |
| Parkman Healthcare Partners LLC | 169,886 | $1,737,934 | 0.38% |